Meghan Adams focuses her practice on patent prosecution. She has extensive knowledge in the areas of molecular biology, imaging, cell sorting, microinjection and other types of embryological manipulation.

Meghan was previously a Technical Specialist at Lathrop & Gage. Prior to moving into the legal field, she completed a joint postdoctoral fellowship in the Burns laboratory at the Cardiovascular Research Center at Massachusetts General Hospital and the Harvard Medical School. Her postdoctoral work was designed to identify and characterize molecules and genetic pathways involved in early cardiovascular development.

Meghan earned her PhD in the laboratory of Marianne Bronner at the California Institute of Technology where her studies were funded by a Thomas Hunt Morgan Fellowship from the Gordon and Betty Moore Foundation. These studies helped to define genes and genetic pathways involved in the development of early neural crest cells. She received an award for teaching while at Caltech and was also active in science outreach through the Sally Ride Science Festival and the YESS program at Caltech.
  • Phi Delta Phi Honor Society – Rehnquist Inn, Suffolk Law School.
  • Ruth L. Kirschstein Institutional National Research Service Award, 2009
  • Thomas Hunt Morgan Fellowship from the Gordon and Betty Moore Foundation, 2002-2007
  • Award for Excellence in Teaching, Biology Undergraduate Student Advisory Committee of the California Institute of Technology, 2004-2005 

Blogs

April 13, 2017

Avoid Ulcers by Crafting a Well-Reasoned Petition



Scientific Publications

The AP-1 transcription factor component Fosl2 potentiates the rate of myocardial differentiation from the zebrafish second heart field. Jahangiri L, Sharpe M, Novikov N, González-Rosa JM, Borikova A, Nevis K, Paffett-Lugassy N, Zhao L, Adams M, Guner-Ataman B, Burns CE, Burns CG. Development. 2016 Jan 1;143(1):113-22.

Zebrafish second heart field development relies on progenitor specification in anterior lateral plate mesoderm and nkx2.5 function. Guner-Ataman B, Paffett-Lugassy N, Adams MS, Nevis KR, Jahangiri L, Obregon P, Kikuchi K, Poss KD, Burns CE, Burns CG. Development. 2013 Mar;140(6):1353-63.

Invited Review: The role of neural crest cells in the endocrine system. Adams MS and Bronner-Fraser M. Endocrine Pathology. 2009 Apr 18.

Epithelial-to-Mesenchymal Transitions: Importance of changing cells’ state in development and disease. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA; Journal of Clinical Investigations. 2009; 119(6):1438-1449.

Discovery of transcription factors and other candidate regulators of neural crest development. Adams MS, Gammill LS, Bronner-Fraser M. Dev Dyn. 2008 Apr;237(4):1021-33.

Investigating regulatory factors and their DNA binding affinities through real time quantitative PCR (RT-QPCR) and chromatin immunoprecipitation (ChIP) assays. Taneyhill LA, Adams MS. Methods Cell Biol. 2008;87:367-89.

Expand All

Meghan Adams focuses her practice on patent prosecution. She has extensive knowledge in the areas of molecular biology, imaging, cell sorting, microinjection and other types of embryological manipulation.

Meghan was previously a Technical Specialist at Lathrop & Gage. Prior to moving into the legal field, she completed a joint postdoctoral fellowship in the Burns laboratory at the Cardiovascular Research Center at Massachusetts General Hospital and the Harvard Medical School. Her postdoctoral work was designed to identify and characterize molecules and genetic pathways involved in early cardiovascular development.

Meghan earned her PhD in the laboratory of Marianne Bronner at the California Institute of Technology where her studies were funded by a Thomas Hunt Morgan Fellowship from the Gordon and Betty Moore Foundation. These studies helped to define genes and genetic pathways involved in the development of early neural crest cells. She received an award for teaching while at Caltech and was also active in science outreach through the Sally Ride Science Festival and the YESS program at Caltech.
  • Phi Delta Phi Honor Society – Rehnquist Inn, Suffolk Law School.
  • Ruth L. Kirschstein Institutional National Research Service Award, 2009
  • Thomas Hunt Morgan Fellowship from the Gordon and Betty Moore Foundation, 2002-2007
  • Award for Excellence in Teaching, Biology Undergraduate Student Advisory Committee of the California Institute of Technology, 2004-2005 

Scientific Publications

The AP-1 transcription factor component Fosl2 potentiates the rate of myocardial differentiation from the zebrafish second heart field. Jahangiri L, Sharpe M, Novikov N, González-Rosa JM, Borikova A, Nevis K, Paffett-Lugassy N, Zhao L, Adams M, Guner-Ataman B, Burns CE, Burns CG. Development. 2016 Jan 1;143(1):113-22.

Zebrafish second heart field development relies on progenitor specification in anterior lateral plate mesoderm and nkx2.5 function. Guner-Ataman B, Paffett-Lugassy N, Adams MS, Nevis KR, Jahangiri L, Obregon P, Kikuchi K, Poss KD, Burns CE, Burns CG. Development. 2013 Mar;140(6):1353-63.

Invited Review: The role of neural crest cells in the endocrine system. Adams MS and Bronner-Fraser M. Endocrine Pathology. 2009 Apr 18.

Epithelial-to-Mesenchymal Transitions: Importance of changing cells’ state in development and disease. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA; Journal of Clinical Investigations. 2009; 119(6):1438-1449.

Discovery of transcription factors and other candidate regulators of neural crest development. Adams MS, Gammill LS, Bronner-Fraser M. Dev Dyn. 2008 Apr;237(4):1021-33.

Investigating regulatory factors and their DNA binding affinities through real time quantitative PCR (RT-QPCR) and chromatin immunoprecipitation (ChIP) assays. Taneyhill LA, Adams MS. Methods Cell Biol. 2008;87:367-89.

Blogs

April 13, 2017

Avoid Ulcers by Crafting a Well-Reasoned Petition